


May 16-17, 2025
The Westin Dallas Southlake
Southlake, Texas
SOCIETY ENDORSEMENTS


COURSE DIRECTORS

Mack Mitchell, MD
Vice President for Medical Affairs
University of Texas Southwestern
Medical Center
Dallas, Texas

Lawrence Schiller, MD
Chair, Institutional Review Boards
Baylor University Medical Center
Dallas, Texas
FACULTY

Bincy Abraham, MD
Houston Methodist Hospital
Houston, Texas

Stephen Hanauer, MD
Northwestern University
Chicago, Illinois

William Lee, MD
UT Southwestern Medical Center
Dallas, Texas

Jackie O'Leary, MD
UT Southwestern Medical Center
Dallas, Texas

William Chey, MD
University of Michigan
Ann Arbor, Michigan

Jana Hashash, MD
Mayo Clinic
Jacksonville, Florida

Ildiko Lingvay, MD
UT Southwestern Medical Center
Dallas, Texas

Nancy Reau, MD
Rush University Medical Center
Chicago, Illinois

Paul Feuerstadt, MD
Yale School of Medicine
New Haven, Connecticut

Eric Lawitz, MD
The Texas Liver Institute
San Antonio, Texas

Marlyn Mayo, MD
UT Southwestern Medical Center
Dallas, Texas

Amit Singal, MD
UT Southwestern Medical Center
Dallas, Texas

Stuart Spechler, MD
Baylor University Medical Center
Dallas, Texas

Ryan Stidham, MD
University of Michigan
Ann Arbor, Michigan
AGENDA
Friday, May 16, 2025
11:30 AM
Lunch and Registration
12:00 PM - 12:45 PM
Strive Towards Treatment Goals
Anish Patel, DO
Industry-Sponsored Event (Non-accredited)
Sponsored by Eli Lilly & Company
12:50 PM - 1:05 PM
Program Overview
Session I
1:05 PM - 1:30 PM
Artificial Intelligence in the Clinic and Endoscopy Laboratory
Ryan Stidham, MD
​
1:30 PM - 1:55 PM
Microbiome Therapeutics
Paul Feuerstadt, MD
​​​
1:55 PM - 2:20 PM
Primary Biliary Cholangitis (PBC): New Treatment Options
Marlyn Mayo, MD
2:20 PM - 2:35 PM
Q&A / Panel Discussion
2:35 PM – 2:50 PM
Break
Session II
​
2:50 PM - 3:15 PM
New and Emerging Treatments for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Eric Lawitz, MD​
​
​3:15 PM - 3:40 PM
What is Metabolic / Alcohol-associated Liver Disease (MetALD)?
Mack Mitchell, MD
​
3:40 PM - 4:10 PM
Updates on the Management of Hepatocellular Carcinoma
Amit Singal, MD ​​
​
4:10 PM - 4:30 PM
Q&A / Panel Discussion
​​​​
4:30 PM – 5:30 PM
Light reception (15 minutes) followed by:
Industry-Sponsored Event (Non-accredited)
TREMFYA® (guselkumab): Now Approved in Adults with Moderately to Severely Active Crohn’s Disease
Harry Thomas, MD
Sponsored by Johnson & Johnson
5:30 PM - 7:00 PM
Reception
​
Saturday, May 17, 2025
​
7:15 AM
Breakfast and Registration
​
7:30 AM - 8:15 AM
Clinical Deep Dive: Unlocking the Treatment Potential of Rezdiffra
Nadege Gunn, MD
Industry-Sponsored Event (Non-accredited)
Sponsored by Madrigal Pharmaceuticals
​
8:20 AM – 8:25 AM
Program Overview
​
Session III
8:25 AM – 8:55 AM
Diagnosis and Management of Cyclic Vomiting Syndrome and Cannabis Hyperemesis Syndrome
Lawrence Schiller, MD
8:55 AM - 9:25 AM
Management of Helicobacter Pylori
William Chey, MD
9:25 AM - 9:55 AM
Integrating Potassium-Competitive Acid Blockers (PCABs) Into Clinical Practice
Stuart Spechler, MD
​
​9:55 AM - 10:20 AM
Q&A / Panel Discussion
10:20 AM – 10:35 AM
Break
10:35 AM - 11:35 AM
Parallel Session (Select One)
-
GI Woes from Head to Toe
-
Inflammatory Bowel Disease
-
Steatotic Liver Disease and Viral Hepatitis
-
Chronic Liver Disease
11:35 AM - 11:50 AM
Lunch Break
11:50 AM - 12:35 PM
Eosinophilic Esophagitis: Clinical Implications of Disease Progression
Gary Falk, MD, MS
Industry-Sponsored Event (Non-accredited)
Sponsored By Sanofi | Regeneron
​
Session IV
12:35 PM - 1:05 PM
Managing the Obesity Epidemic
Ildiko Lingvay, MD
​
1:05 PM - 1:35 PM
Acute-on-Chronic Liver Failure and the Management of Critically Ill Patients With Cirrhosis
Jackie O'Leary, MD
​
1:35 PM - 2:00 PM
Risk Stratification and Management of Portal Hypertension and Varices in Cirrhosis:
Understanding the New AASLD Practice Guidance
Nancy Reau, MD
​
2:00 PM - 2:25 PM
Hepatitis B and D: Natural History and Treatment
William Lee, MD
2:25 PM - 2:40 PM
Q&A / Panel Discussion
2:40 PM - 2:50 PM
Break
Session V
2:50 PM - 3:20 PM
Simplifying the Treatment Algorithm for Moderate-Severe Inflammatory Bowel Disease (IBD): A Practical Approach
Stephen Hanauer, MD
​
3:20 PM - 3:50 PM
Point of Care IUS in the Management of IBD
Bincy Abraham, MD
​
3:50 PM - 4:20 PM
Diet & Nutritional Therapy for IBD
Jana Al Hashash, MD
4:20 PM - 4:35 PM
Q&A / Panel Discussion
4:35 PM - 4:45 PM
Meeting Wrap-up

VENUE
The Westin
Dallas Southlake
1200 E. State HWY 114
Southlake, TX 76092
